DRC

The primary regulatory authority for health products in the Democratic Republic of Congo (DRC) is the Direction de la Pharmacie, du Médicament et des Plantes Médicinales (DPPM), operating under the Ministry of Public Health, Hygiene and Prevention. The principal governing legislation is the Loi-Cadre on pharmaceutical practice and the related ministerial decrees that define registration, importation, and post-market surveillance requirements for pharmaceuticals, medical devices, diagnostics, and increasingly digital health solutions. All health products intended for sale or distribution in the DRC must obtain official marketing authorization from the DPPM prior to commercialization. The review process involves submission of a technical dossier, laboratory verification where applicable, and ministerial approval, with final registration certificates issued for a defined validity period subject to renewal.

Applicants are required to designate a locally established representative or importer who assumes legal responsibility for the product on the Congolese market. Dossiers are generally expected to follow the Common Technical Document (CTD) format, though the DPPM also accepts submissions aligned with the ACTD format recognized by regional bodies such as the African Medicines Regulatory Harmonization (AMRH) initiative. The DRC is a member state of the African Union and participates in efforts coordinated through the African Medicines Agency (AMA), which may progressively influence harmonization of standards. Recent reforms have sought to strengthen pharmacovigilance frameworks, clarify requirements for in-vitro diagnostics and medical devices, and introduce digital submission pathways, although implementation capacity and enforcement remain ongoing challenges across the country.

Public procurement of health products in the DRC is coordinated primarily through the Ministry of Public Health, Hygiene and Prevention, with the Centrale d'Achat des Médicaments Essentiels (CAMEC) serving as the principal national purchasing and distribution entity for essential medicines and health commodities at the central level. Procurement decisions for the public sector are governed by national public procurement law administered by the Direction Générale du Contrôle des Marchés Publics (DGCMP). Given the DRC's highly decentralized geography, provincial health divisions (Divisions Provinciales de la Santé) play a significant operational role in sub-national distribution and local procurement, though central framework agreements often govern product selection and pricing. Tendering processes for larger government contracts typically require product registration with the DPPM, compliance with national quality standards, and in some cases local content or partnership provisions.

The DRC health market is heavily reliant on donor-funded and international procurement channels, which represent a substantial share of total health commodity financing. Key partners include the Global Fund to Fight AIDS, Tuberculosis and Malaria, USAID through mechanisms such as PEPFAR and the President's Malaria Initiative, UNICEF Supply Division, Gavi the Vaccine Alliance for immunization commodities, and the World Bank through health sector development projects. These channels often procure through pre-qualified international suppliers using WHO prequalification or stringent regulatory authority (SRA) approval as a benchmark, which can accelerate access for products meeting those standards. Local manufacturing capacity in the DRC remains limited, and while government policy expresses intent to promote local pharmaceutical production in alignment with the Africa Medicines Manufacturing for Africa agenda, formal local manufacturing preference policies are not yet systematically enforced in procurement practice.